Company profile
Silence Therapeutics PLC
Pipeline6 assets
- DivesiranSLN124 / TMPRSS6 / siRNA / Hematologic ConditionsPolycythemia VeraOther Blood Disorders
- ZerlasiranSLN360 / LPA / siRNA / Cardiovascular DiseaseElevated Lp(a)Atherosclerotic Cardiovascular Disease
- SLN312SLN312 / ANGPTL3 / siRNA / CardiometabolicDyslipidemia
- SLN548SLN548 / CFB / siRNA / Complement
- SLN365SLN365 / GPR146 / siRNA / CardiometabolicHomozygous familial hypercholesterolemia (HoFH)
- SLN098SLN098 / INHBE / siRNA / MetabolicObesity